2008 Annual Meeting of the Division of Nuclear Physics
Volume 53, Number 12
Thursday–Sunday, October 23–26, 2008;
Oakland, California
Session CC: Mini-Symposium: Applications of Nuclear Physics from Earth to Outer Space
10:30 AM–12:18 PM,
Friday, October 24, 2008
Room: Jewett Ballroom A-B
Chair: Cynthia Keppel, Hampton University
Abstract ID: BAPS.2008.DNP.CC.1
Abstract: CC.00001 : Nuclear Physics and Radiobiology - Issues for Humans in Space and on Earth
10:30 AM–11:06 AM
Preview Abstract
Abstract
Author:
Ram Tripathi
(NASA Langley Research Center)
Nuclear physics is playing a vital role in human biological
applications, specifically in planned space missions, in hadron
radiotherapy, and in low dose radiobiology. While seemingly
disparate, these and other areas share a common need for the
understanding of nuclear interactions in biological systems.
Radiobiology continues to provide valuable information that
will help develop better methods for using radiation in the
treatment of disease as well as provide a scientific basis for
radiation protection standards. NASA is now focused on the
agency's vision for space exploration encompassing a broad
range of human and robotic missions including missions to the
Moon, Mars and beyond. As a result, there is a focus on long
duration space missions. Protection from hazards of space
radiation has been identified as one of the five NASA critical
areas for human space flight. The cost effective design of
spacecraft demands a very stringent requirement on the
optimization process. Exposures from the hazards of severe
space radiation in deep space and/or long duration missions are
very different from that of low earth orbit, and much needs to
be done about their effects. However, it is clear that
revolutionary technologies will need to be developed. Here on
earth, particulate radiation treatment for cancer, such as
proton radiotherapy, is playing an increasing important role,
while the biological effectiveness remains less well understood
than for x-rays and other forms of medical radiation
treatments. Advanced imaging, dosimetric, Monte Carlo, and
other techniques from nuclear physics are utilized to study the
molecular basis of fractionation dependency and other tumor and
normal tissue radiation responses, such as radiosensitivity.
Moreover, advances developed by biological research efforts,
such as the sequencing of the human genome, have opened new
horizons for radiobiology. New techniques have made it possible
to determine at the cellular / molecular level how living
systems respond even to low doses of radiation. I will discuss
the interplay between nuclear physics and human biological
applications; Starting with high dose exposure in space
applications, to controlled exposure in radiotherapy, and
finally, low dose radiobiology. I will project how cellular
level living system activities may provide the much needed
impact of radiation exposure on living tissues in these
applications.
To cite this abstract, use the following reference: http://meetings.aps.org/link/BAPS.2008.DNP.CC.1